Caroline Ling, PhD

Executive Director and HTA Specialist, Market Access and Outcomes Strategy

PhD, Genetics
BSc, Biology
University of Nottingham, Nottingham, United Kingdom

Caroline Ling, PhD, is an Executive Director and HTA Specialist in the Market Access and Outcomes Strategy group in Manchester, UK at RTI-HS. Dr. Ling has over 20 years of experience with market access and health economic consultancies and is able to deliver a broad spectrum of strategic and tactical market access projects for both global and local clients, including systematic and pragmatic literature reviews, global value dossiers, health technology assessment submissions, interactive payer tools, value communication materials, and payer research. Dr. Ling has experience in a wide range of therapeutic areas, including hematology, oncology, autoimmune disorders, renal disease, diabetes, mental health, and cardiovascular disorders.